این پروتئین در تکامل بافتهای جنینی و همچنین در رشد سلولهای سرطانی نقش مهمی ایفا میکند و با آنکه نقش دقیق آن هنوز مشخص نیست، اما تصور بر آن است که بهعنوان یک سرکوبگر تومور عمل میکند. اتصال این ژن به یک دومین سرچنگالی سبب بروز رابدومیوسارکوم آلوئولار میگردد. همچنین در موشها، جهش در ژن PAX7 با ناهنجاریهای بینی و فک بالا همراه بودهاست.[۱]
↑Mansouri A, Stoykova A, Torres M, Gruss P (March 1996). "Dysgenesis of cephalic neural crest derivatives in Pax7-/- mutant mice". Development. 122 (3): 831–8. PMID8631261.
Blake J, Ziman MR (April 2003). "Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?". Histology and Histopathology. 18 (2): 529–39. PMID12647804.
Shapiro DN, Sublett JE, Li B, Valentine MB, Morris SW, Noll M (September 1993). "The gene for PAX7, a member of the paired-box-containing genes, is localized on human chromosome arm 1p36". Genomics. 17 (3): 767–9. doi:10.1006/geno.1993.1404. PMID7902328.
Cross SH, Charlton JA, Nan X, Bird AP (March 1994). "Purification of CpG islands using a methylated DNA binding column". Nature Genetics. 6 (3): 236–44. doi:10.1038/ng0394-236. PMID8012384.
Schäfer BW, Mattei MG (July 1993). "The human paired domain gene PAX7 (Hup1) maps to chromosome 1p35-1p36.2". Genomics. 17 (1): 249–51. doi:10.1006/geno.1993.1315. PMID8104868.
Barr FG, Nauta LE, Davis RJ, Schäfer BW, Nycum LM, Biegel JA (Jan 1996). "In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma". Human Molecular Genetics. 5 (1): 15–21. doi:10.1093/hmg/5.1.15. PMID8789435.
Vorobyov E, Mertsalov I, Dockhorn-Dworniczak B, Dworniczak B, Horst J (October 1997). "The genomic organization and the full coding region of the human PAX7 gene". Genomics. 45 (1): 168–74. doi:10.1006/geno.1997.4915. PMID9339373.
Magnaghi P, Roberts C, Lorain S, Lipinski M, Scambler PJ (September 1998). "HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3". Nature Genetics. 20 (1): 74–7. doi:10.1038/1739. PMID9731536.
Margue CM, Bernasconi M, Barr FG, Schäfer BW (June 2000). "Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR". Oncogene. 19 (25): 2921–9. doi:10.1038/sj.onc.1203607. PMID10871843.
Kondrashov AV, Pospelov VA (2002). "[In vitro modelling of the interactions between the promoter and enhancer complexes]". Tsitologiia. 43 (8): 764–71. PMID11601392.
Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG (June 2002). "PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group". Journal of Clinical Oncology. 20 (11): 2672–9. doi:10.1200/JCO.2002.03.137. PMID12039929.
Syagailo YV, Okladnova O, Reimer E, Grässle M, Mössner R, Gattenlöhner S, Marx A, Meyer J, Lesch KP (July 2002). "Structural and functional characterization of the human PAX7 5'-flanking regulatory region". Gene. 294 (1–2): 259–68. doi:10.1016/S0378-1119(02)00798-9. PMID12234688.
Tomescu O, Xia SJ, Strezlecki D, Bennicelli JL, Ginsberg J, Pawel B, Barr FG (August 2004). "Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression". Laboratory Investigation. 84 (8): 1060–70. doi:10.1038/labinvest.3700125. PMID15184910.
Vorobyov E, Horst J (November 2004). "Expression of two protein isoforms of PAX7 is controlled by competing cleavage-polyadenylation and splicing". Gene. 342 (1): 107–12. doi:10.1016/j.gene.2004.07.030. PMID15527970.